Tissue Microarray Market to grow at a CAGR of 7.75% by 2026 |Hospitals Segment to be Significant for Revenue Generation| 17000+ Technavio Reports

·4 min read

NEW YORK, Dec. 7, 2021 /PRNewswire/ -- The tissue microarray market share growth by the hospital segment will be significant for revenue generation. Tissue microarray is used for disease diagnosis in hospitals. In disease diagnosis applications, tissue microarrays have a high potential for analyzing more than thousands of tumor samples on a single slide. They also allow a high-throughput analysis of proteins and genes that can provide vital indications in cancer diagnosis. The global tissue microarray market is expected to grow by USD 3.14 billion from 2021 to 2206 at a CAGR of 7.75% as per the latest report by Technavio.

Attractive Opportunities in Tissue Microarray Market by End-user and Geography - Forecast and Analysis 2022-2026
Attractive Opportunities in Tissue Microarray Market by End-user and Geography - Forecast and Analysis 2022-2026

For more insights on the Tissue Microarray Market - View a FREE sample report in MINUTES

Read the 120-page report with TOC on "Tissue Microarray Market Analysis Report by End-user (hospitals, clinics, and diagnostics centers) and Geography (North America, Europe, Asia, and ROW), and the Segment Forecasts,2022-2026". Gain competitive intelligence about market leaders. Track key industry opportunities, trends and threats. Information on marketing, brand, strategy and market development, sales, and supply functions. https://www.technavio.com/report/report/tissue-microarray-market-industry-analysis

The tissue microarray market is driven by the growing number of cancer cases worldwide. However, factors such as the high cost of instruments and maintenance may impede the market growth. The holistic analysis of the drivers & challenges will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Some of key Tissue Microarray Players:

The tissue microarray market is concentrated and the vendors are deploying various organic and inorganic growth strategies to compete in the market.

  • Agilent Technologies Inc.

  • Arrayit Corp.

  • Bio Rad Laboratories Inc.

  • Bio Techne Corp.

  • Enzo Biochem Inc.

  • Illumina Inc.

  • Molecular Devices LLC

  • OriGene Technologies Inc.

  • PerkinElmer Inc.

  • Thermo Fisher Scientific Inc.

Get lifetime access to our Technavio Insights. Subscribe now to our most popular "Lite Plan" billed annually at USD 3000. View 3 reports monthly and Download 3 Reports Annually!

Tissue Microarray Market End-user Outlook (Revenue, USD bn, 2021-2026)

  • Hospitals - size and forecast 2021-2026

  • Clinics - size and forecast 2021-2026

  • Diagnostics centers - size and forecast 2021-2026

Tissue Microarray Market Geography Outlook (Revenue, USD bn, 2021-2026)

  • North America - size and forecast 2021-2026

  • Europe - size and forecast 2021-2026

  • Asia - size and forecast 2021-2026

  • ROW - size and forecast 2021-2026

For additional information on Segmentation -Grab an Exclusive Sample Report

Related Reports:
In-vitro Diagnostics Market -The in-vitro diagnostics market share should rise by USD 35.77 billion from 2021 to 2025 at a CAGR of 7.95%. Download a free sample now!

Molecular Biology Enzymes, Kits, and Reagents Market -The molecular biology enzymes, kits, and reagents market share should rise by USD 13.09 billion from 2021 to 2025 at a CAGR of 14.61%. Download a free sample now!

Tissue Microarray Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 7.75%

Market growth 2022-2026

USD 3.14 billion

Market structure

Concentrated

YoY growth (%)

5.71

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 36%

Key consumer countries

US, Canada, Germany, China, UK, Japan, France, India, and Mexico

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Agilent Technologies Inc., Arrayit Corp., Bio Rad Laboratories Inc., Bio Techne Corp., Enzo Biochem Inc., Illumina Inc., Molecular Devices LLC, OriGene Technologies Inc., PerkinElmer Inc., and Thermo Fisher Scientific Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Technavio (PRNewsfoto/Technavio)
Technavio (PRNewsfoto/Technavio)
Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/tissue-microarray-market-to-grow-at-a-cagr-of-7-75-by-2026-hospitals-segment-to-be-significant-for-revenue-generation-17000-technavio-reports-301438237.html

SOURCE Technavio

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting